Previous Article | Next Article ![]()
Antimicrob Agents Chemother. 1979 August; 16(2): 234-236
Copyright © 1979, American Society for Microbiology. All Rights Reserved.
1 Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium
2 Department of Chemistry, University of Birmingham, Birmingham B15 2TT, Great Britain
ABSTRACT
The pharmacokinetics of the newly developed anti-herpes agent, E-5-(2-bromovinyl)-2'-deoxyuridine, was compared with that of the standard anti-herpes drug 5-iodo-2'-deoxyuridine. Both compounds were administered to mice at 100 mg/kg by either the intraperitoneal, subcutaneous, or oral route. The active blood drug levels achieved by E-5-(2-bromovinyl)-2'-deoxyuridine were considerably higher than those attained by 5-iodo-2'-deoxyuridine (serum peak concentrations: 40 to 100 and 4 to 10 µg/ml, respectively). Active blood drug levels could still be found 320 min after oral administration of E-5-(2-bromovinyl)-2'-deoxyuridine.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»